https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-12 / J Transl Med 2017 05;15(1):104
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-12 / J Transl Med 2017 05;15(1):1042017-05-12 00:00:002019-02-15 08:47:31A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-04 / Oncol Lett 2017 Jul;14(1):73-78
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-04 / Oncol Lett 2017 Jul;14(1):73-782017-05-04 00:00:002019-02-15 08:35:48Treatment outcome analysis of chemotherapy combined with modulated electro-hyperthermia compared with chemotherapy alone for recurrent cervical cancer, following irradiation
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-05-03 / Clin. Cancer Res. 2017 Aug;23(16):4556-4568
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-05-03 / Clin. Cancer Res. 2017 Aug;23(16):4556-45682017-05-03 00:00:002019-02-15 08:45:43Phase I Trial of Intratumoral Injection of Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8 T-cell Infiltration
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-28 / J. Therm. Biol. 2017 Jul;67:9-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-28 / J. Therm. Biol. 2017 Jul;67:9-142017-04-28 00:00:002019-02-15 08:32:53Hyperthermia enhances bortezomib-induced apoptosis in human white blood cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-27 / Sci Rep 2017 04;7(1):1217
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-27 / Sci Rep 2017 04;7(1):12172017-04-27 00:00:002021-11-15 20:07:45Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-27 / Radiat Oncol 2017 Apr;12(1):75
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-27 / Radiat Oncol 2017 Apr;12(1):752017-04-27 00:00:002019-02-15 08:35:47A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-27 / Electromagn Biol Med 2017;36(3):248-258
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-27 / Electromagn Biol Med 2017;36(3):248-2582017-04-27 00:00:002019-02-15 09:18:15Temperature measurements in a capacitive system of deep loco-regional hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-22 / J. Neurooncol. 2017 Jun;133(2):223-235
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-22 / J. Neurooncol. 2017 Jun;133(2):223-2352017-04-22 00:00:002019-02-15 08:47:31Dendritic cell based vaccination strategy: an evolving paradigm
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-21 / Oncol Lett 2017 Jun;13(6):4959-4964
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-21 / Oncol Lett 2017 Jun;13(6):4959-49642017-04-21 00:00:002017-04-21 00:00:00Treatment outcomes of concurrent hyperthermia and chemoradiotherapy for pancreatic cancer: Insights into the significance of hyperthermia treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-20 / Oncoimmunology 2017;6(6):e1319044
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-20 / Oncoimmunology 2017;6(6):e13190442017-04-20 00:00:002019-02-15 08:46:16Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer